Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Glucose Transporters

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:

Inborn Errors of Metabolism

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...

Glycolysis: Preparatory Phase

Glycolysis: Preparatory Phase

In cellular metabolism (the complete breakdown of glucose to extract energy), glycolysis is the first step. Glycolysis takes place in the cytoplasm of both prokaryotic and eukaryotic cells. Glucose enters heterotrophic cells in two ways. One method is through secondary active transport, where the transport takes place against the glucose concentration gradient. The other mechanism uses a group of integral proteins called GLUT proteins, also known as glucose transporter proteins. These...

Energy-requiring Steps of Glycolysis

Energy-requiring Steps of Glycolysis

Glucose is the source of nearly all energy used by organisms. The first step of converting glucose into usable energy is called glycolysis. Glycolysis occurs in the cytosol of the cell over two phases: an energy-requiring phase and an energy-releasing phase. Over the first three steps, glucose is converted into different forms and attached to two phosphate groups donated by two ATP molecules, resulting in an unstable sugar. In the next two stages, the unstable sugar splits into two sugar...

Other Glycolytic Pathways

Other Glycolytic Pathways

The pentose phosphate pathway (PPP) operates in parallel with glycolysis, facilitating the metabolism of both pentoses and glucose. This pathway consists of two distinct phases: the oxidative and non-oxidative phases. While it does not directly generate ATP, the intermediates formed during the process can integrate into glycolysis, contributing to cellular energy metabolism when required.Oxidative Phase: NADPH ProductionThe oxidative phase of the pentose phosphate pathway is primarily...

ATP Energy Storage and Release

ATP Energy Storage and Release

ATP is a highly unstable molecule. Unless quickly used to perform work, ATP spontaneously dissociates into ADP and inorganic phosphate (Pi), and the free energy released during this process is lost as heat. The energy released by ATP hydrolysis is used to perform work inside the cell and depends on a strategy called energy coupling. Cells couple the exergonic reaction of ATP hydrolysis with endergonic reactions, allowing them to proceed.
One example of energy coupling using ATP involves a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Choosing Covariate Balancing Methods for Causal Inference: Practical Insights From a Simulation Study.

Statistics in medicine·2026

Same author

2025 update of the National French consensus on gene lists for the diagnosis of muscle diseases using high-throughput sequencing.

Journal of neuromuscular diseases·2026

Same author

Vitamin-Responsive Disorders: From Molecular Basis to Clinical Presentation and Therapy.

Journal of inherited metabolic disease·2026

Same author

Better 10-Year Cerebrovascular Outcome After Transplant Than on Standard-Care in Sickle Cell Anemia: DREPAGREFFE Trial.

American journal of hematology·2026

Same author

Clustering methods for categorical time series and sequences : a scoping review.

BMC medical research methodology·2026

Same author

Prospective gait analysis in patients from the French registry of glycogen storage disease type III: implications for clinical trials.

Journal of neurology·2026

Search research articles

Related Experiment Video

Updated: Jun 1, 2026

Spectrophotometric Methods for the Study of Eukaryotic Glycogen Metabolism

Spectrophotometric Methods for the Study of Eukaryotic Glycogen Metabolism

Published on: August 19, 2021

Glucose-6-phosphatase deficiency.

Roseline Froissart¹, Monique Piraud, Alix Mollet Boudjemline

¹Centre de Référence Maladies Héréditaires du Métabolisme Hépatique, Service de Pédiatrie, APHP, Clamart cedex, France.

Orphanet Journal of Rare Diseases

|May 24, 2011

Summary

Glucose-6-phosphatase deficiency (GSDI) is an inherited metabolic disorder affecting glycogen metabolism. Early diagnosis and dietary management are crucial for preventing hypoglycemia and ensuring a near-normal lifespan for affected individuals.

More Related Videos

Measuring Glucose Uptake in Drosophila Models of TDP-43 Proteinopathy

Measuring Glucose Uptake in Drosophila Models of TDP-43 Proteinopathy

Published on: August 3, 2021

Measuring Uptake of the Glucose Analog, 6-(N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)Amino)-6-Deoxyglucose, in Intact Murine Neural Retina

Measuring Uptake of the Glucose Analog, 6-(N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)Amino)-6-Deoxyglucose, in Intact Murine Neural Retina

Published on: March 14, 2025

Related Experiment Videos

Last Updated: Jun 1, 2026

Spectrophotometric Methods for the Study of Eukaryotic Glycogen Metabolism

Spectrophotometric Methods for the Study of Eukaryotic Glycogen Metabolism

Published on: August 19, 2021

Measuring Glucose Uptake in Drosophila Models of TDP-43 Proteinopathy

Measuring Glucose Uptake in Drosophila Models of TDP-43 Proteinopathy

Published on: August 3, 2021

Measuring Uptake of the Glucose Analog, 6-(N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)Amino)-6-Deoxyglucose, in Intact Murine Neural Retina

Measuring Uptake of the Glucose Analog, 6-(N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)Amino)-6-Deoxyglucose, in Intact Murine Neural Retina

Published on: March 14, 2025

Area of Science:

Biochemistry
Genetics
Pediatrics

Background:

Glucose-6-phosphatase deficiency (GSDI) encompasses inherited metabolic disorders, including GSDIa and GSDIb, marked by impaired glycogen metabolism.
These conditions lead to glycogen and fat accumulation in the liver, causing hepatomegaly, growth retardation, and poor fasting tolerance.

Purpose of the Study:

To provide a comprehensive overview of Glucose-6-phosphatase deficiency (GSDI), covering its clinical manifestations, genetic basis, diagnosis, and management.
To highlight the differences between GSDIa and GSDIb and discuss potential long-term complications and treatment strategies.

Main Methods:

Review of clinical presentations, including hypoglycemia, hepatomegaly, growth issues, and specific symptoms of GSDIa and GSDIb.
Analysis of genetic mutations in G6PC (GSDIa) and SLC37A4 (GSDIb) genes.
Discussion of diagnostic approaches, including clinical evaluation, biochemical tests, and genetic analysis.
Overview of current management strategies, including dietary interventions and surgical options like liver and kidney transplantation.

Main Results:

GSDI presents in infancy with hypoglycemia and hepatomegaly; GSDIa accounts for 80% of cases.
Genetic analysis of G6PC and SLC37A4 genes is the primary diagnostic method, reducing the need for liver biopsies.
Long-term complications include hepatic adenomas and renal issues; neutropenia is specific to GSDIb.
Dietary management is key to preventing hypoglycemia, while transplantation addresses severe complications.

Conclusions:

GSDI requires early diagnosis and consistent management to mitigate severe health consequences.
Genetic testing has become the gold standard for diagnosing GSDI, offering precise subtype identification.
With appropriate care, individuals with GSDI can achieve a near-normal lifespan, though long-term monitoring for hepatic and renal complications is essential.